Las Vegas Sands (NYSE:LVS)’s share price plunged -3.35% or -1.95 to reach at $56.33 during previous trading session. A total of 6.67 Million shares exchanged hands, whereas the company’s average trading volume stands at 4.19 Million shares. Las Vegas Sands (NYSE:LVS) has a market capitalization of $44.88 Billion and most recently 796.73 Million outstanding shares have been calculated.

According to sentiments of 16 analysts the mean estimates of short term price target for the company’s stock is marked at $78.57. The most optimistic analyst sees the stock reaching $88 while the most conventional predicts the target price at $65.

In terms of Buy/Sell recommendations, 10 analysts have a consensus rating of 2.25 on the shares of Las Vegas Sands (NYSE:LVS). Out of rating recommendations 3 have given the stock a Buy while 6 recommend the stock as Outperform. 9 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Las Vegas Sands (NYSE:LVS)’s shares slipped -7.38% in the past week and plunged -6.89% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -22.16% while its year to date performance is at -18.94%.

While taking a glance at financials, we can look at a number of key indicators. Las Vegas Sands (NYSE:LVS) has a Return on Assets (ROA) of 17.9. The company currently has a Return on Equity (ROE) of 56.4 and a Return on Investment (ROI) of 19.5. Average true range (ATR-14) of the company sets at 1.37, along with its weekly and monthly volatility of 2.81% and 2.00% respectively. Relative strength index (RSI-14) for Las Vegas Sands (NYSE:LVS) is at 25.46. Beta value of the stock stands at 1.6.

The company’s price to free cash flow for trailing twelve months is 40.84. Its quick ratio for most recent quarter is 1.7 along with current ratio for most recent quarter of 1.7. Total debt to equity ratio of Las Vegas Sands (NYSE:LVS) for most recent quarter is 1.58 whereas long term debt to equity ratio for most recent quarter is 1.56.

Shares of Johnson & Johnson (NYSE:JNJ) plunged -1.06% or -1.47 to reach at $137.73 during previous trading session. Johnson & Johnson (NYSE:JNJ) has a market capitalization of $370.16 Billion and most recently 2.69 Billion outstanding shares have been calculated. A total of 6.68 Million shares exchanged hands, whereas the company’s average trading volume stands at 6.1 Million shares.

According to 19 analysts Johnson & Johnson (NYSE:JNJ)’s price will reach at $143.79 during 52 weeks. Stock’s minimum price target estimates has been figured out at $119 while the maximum price target forecast is established at $160.

According to the recommendations from 15 analysts stock has mean rating of 2.07 on the shares of Johnson & Johnson (NYSE:JNJ). Out of rating recommendations 5 have given the stock a Buy while 4 recommend the stock as Outperform. 9 have given the stock a Hold rating, 0 as Underperform and 1 as Sell.

Shares of Johnson & Johnson (NYSE:JNJ) slipped -0.94% in the past week and plunged -0.56% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 5.6% while its year to date performance is at -1.42%.

Total debt to equity ratio of Johnson & Johnson (NYSE:JNJ) for most recent quarter is 0.51 whereas long term debt to equity ratio for most recent quarter is 0.47. The company’s price to free cash flow for trailing twelve months is 39.74. Its quick ratio for most recent quarter is 1.3 along with current ratio for most recent quarter of 1.7.

Average true range (ATR-14) of the company sets at 1.76, along with its weekly and monthly volatility of 1.38% and 1.21% respectively. Relative strength index (RSI-14) for Johnson & Johnson (NYSE:JNJ) is at 48.74. Beta value of the stock stands at 0.65. Johnson & Johnson (NYSE:JNJ) has a Return on Assets (ROA) of 0.9. The company currently has a Return on Equity (ROE) of 2.1 and a Return on Investment (ROI) of 15.7.